Suchergebnisse - "Citterio, Giovanni"

PubPharm (29)

1

Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma : final results of a phase 2 trial

enthalten in: Blood advances | 2020

von Ferreri, A. | Calimeri, T. | Ponzoni, M. | +21

2

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

enthalten in: Blood | 2019

von Ferreri, A. | Calimeri, T. | Conte, G. | +18

CommentIn: Blood. 2019 Jul 18;134(3):221-222. - PMID 31320363

3

Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma

enthalten in: Expert review of neurotherapeutics | 2018

von Citterio, G. | Calimeri, T. | Ferreri, A.

4

Primary central nervous system lymphoma

enthalten in: Critical reviews in oncology/hematology | 2017

von Citterio, G. | Reni, M. | Gatta, G. | +1

5

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement : Final Results of a Multicenter Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Ferreri, A. | Donadoni, G. | Cabras, M. | +15

CommentIn: J Clin Oncol. 2015 Nov 20;33(33):3851-3. - PMID 26282665

6

Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era

enthalten in: British journal of haematology | 2015

von Ferreri, A. | Bruno-Ventre, M. | Donadoni, G. | +8

7

Present and future treatment options for primary CNS lymphoma

enthalten in: Expert opinion on pharmacotherapy | 2015

von Citterio, G. | Reni, M. | Ferreri, A.

8

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2015

von Ferreri, A. | Donadoni, G. | Cabras, M. | +15

9

Present and future treatment options for primary CNS lymphoma

enthalten in: Expert opinion on pharmacotherapy | 2015

von Citterio, G. | Reni, M. | Ferreri, A.

10

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

enthalten in: British journal of haematology | 2015

von Ferreri, A. | Bruno‐Ventre, M. | Donadoni, G. | +8